ArcherDX’s Companion Diagnostic Assay for both Liquid Biopsy and Tissue Specimens Granted Breakthrough Device Designation by FDA January 8, 2019
Merck KGaA, Darmstadt, Germany Selects ArcherDX for Strategic Global Companion Diagnostic Assay Development Collaboration October 3, 2018
ArcherDX Names Former Foundation Medicine Executive Steven Kafka, Ph.D. to its Board of Directors September 5, 2018
